Journal articles on the topic 'Diffuse midline glioma (DMG)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Diffuse midline glioma (DMG).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Barron, Tara, Belgin Yalçın, Aaron Mochizuki, Evan Cantor, Kiarash Shamardani, Dana Tlais, Andrea Franson, et al. "CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i11. http://dx.doi.org/10.1093/neuonc/noad073.044.
Al Sharie, Sarah, Dima Abu Laban, Jamil Nazzal, Shahad Iqneibi, Sura Ghnaimat, Abdallah Al-Ani, and Maysa Al-Hussaini. "Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East." Cancers 15, no. 18 (September 13, 2023): 4545. http://dx.doi.org/10.3390/cancers15184545.
Ibdah, Haleem, Shervin Pejhan, Lee Ang, Cynthia Hawkins, Barbara Fisher, Joseph Megyesi, and Maria MacDonald. "CEREBELLAR DIFFUSE MIDLINE GLIOMA, H3K27M ALTERED IN A FIFTY-FIVE-YEAR-OLD PATIENT." Neuro-Oncology Advances 5, Supplement_2 (July 1, 2023): i6. http://dx.doi.org/10.1093/noajnl/vdad071.026.
Choi, Seonah, In-Ho Jung, Jaejoon Lim, Ju Hyung Moon, Eui Hyun Kim, Se Hoon Kim, Seok-Gu Kang, and Jong Hee Chang. "PATH-06. SURVIVAL ANALYSIS FOR ADULT MIDLINE GLIOMA: DO ADULT MIDLINE GLIOMAS WITH THE H3 K27M MUTATION REALLY HAVE POOR PROGNOSIS?" Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii150—vii151. http://dx.doi.org/10.1093/neuonc/noac209.579.
Nakatogawa, Hirokazu, Hiroshi Kawaji, Nobuhide Hayashi, Junya Fukai, Noriyuki Kijima, Tomoko Shofuda, Ema Yoshioka, et al. "10184-BT-14 CLINICAL FEATURE OF HEMISPHERIC GLIOMA WITH H3F3A, PEDIATRIC-TYPE HIGH GRADE GLIOMA, H3 K27-ALTERED, NEC AND DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT, CNS WHO GRADE 4." Neuro-Oncology Advances 5, Supplement_5 (December 1, 2023): v18—v19. http://dx.doi.org/10.1093/noajnl/vdad141.074.
Morscio, Julie, Sandra Jacobs, and Frederik De Smet. "DIPG-55. DISSECTING THE ECOSYSTEM OF PEDIATRIC DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.108.
Knowles, Truman, Shejuan An, Tina Huang, Jin Qi, and Amanda Saratsis. "DIPG-01. LIN28B EXPRESSION IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i12. http://dx.doi.org/10.1093/neuonc/noad073.048.
Knowles, Truman, Shejuan An, Tina Huang, Jin Qi, and Amanda Saratsis. "CSIG-11. LIN28B EXPRESSION IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 25, Supplement_5 (November 1, 2023): v42. http://dx.doi.org/10.1093/neuonc/noad179.0167.
Knowles, Truman, Shejuan An, Tina Huang, Jin Qi, and Amanda Saratsis. "DIPG-02. LIN28B EXPRESSION IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.056.
Larsen, Alexandra Giantini, Maricruz Rivera, David Pisapia, Sameer Farouk Sait, Matthias Karajannis, Jeffrey Greenfield, and Mark Souweidane. "DIPG-44. DIFFUSE MIDLINE GLIOMA WITH EXTRACRANIAL METASTASIS." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i23. http://dx.doi.org/10.1093/neuonc/noad073.091.
Butterfield, Hannah E., Juliana Hofstatter Azambuja, Lisa Maurer, Dong Hu, Andrea F. Cruz, Matthew E. Halbert, Taylor A. Gatesman, et al. "DIPG-85. MALT1 IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.138.
Miguel Llordes, Gloria, Víctor Manuel Medina Pérez, Beatriz Curto Simón, Irene Castells-Yus, Silvia Vázquez Sufuentes, and Alberto J. Schuhmacher. "Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma." Journal of Clinical Medicine 12, no. 16 (August 12, 2023): 5261. http://dx.doi.org/10.3390/jcm12165261.
Klenner, Marbod, Pia Freidel, Mariella G. Filbin, and Alexander Beck. "DIPG-39. New preclinical models for Diffuse Midline Glioma." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i27. http://dx.doi.org/10.1093/neuonc/noac079.096.
Tanaka, Kazuhiro, Hiroaki Nagashima, Shunsuke Yamanishi, Hirofumi Iwahashi, Tomoo Itoh, and Takashi Sasayama. "MPC-16 CHARACTERISTICS AND PROGNOSTIC FACTORS OF H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA." Neuro-Oncology Advances 4, Supplement_3 (December 1, 2022): iii15—iii16. http://dx.doi.org/10.1093/noajnl/vdac167.057.
Tanaka, K., H. Nagashima, S. Yamanishi, T. Itoh, and T. Sasayama. "P10.11.A CHARACTERISTICS OF DIFFUSE MIDLINE GLIOMA WITH H3 K27M MUTATION IN ADULTS." Neuro-Oncology 25, Supplement_2 (September 1, 2023): ii64. http://dx.doi.org/10.1093/neuonc/noad137.209.
Nakatogawa, Hirokazu, Hiroshi Kawaji, Nobuhide Hayashi, Junya Fukai, Noriyuki Kijima, Tomoko Shofuda, Ema Yoshioka, et al. "MPC-15 CLINICAL FEATURE OF NON-MIDLINE GLIOMA WITH H3F3A GENE MUTATION." Neuro-Oncology Advances 4, Supplement_3 (December 1, 2022): iii15. http://dx.doi.org/10.1093/noajnl/vdac167.056.
Holliday, Holly, Anahid Ehteda, Aaminah Khan, Brian Krug, Jourdin R. C. Rouaen, Nisitha Jayatilleke, Chelsea Mayoh, et al. "DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i18. http://dx.doi.org/10.1093/neuonc/noac079.063.
Willimas, E. A., P. K. Brastianos, H. Wakimoto, S. Santagata, D. P. Cahill, and T. A. Juratli. "P04.04.A A comprehensive genomic study of 390 H3F3A-mutant pediatric-type diffuse high-grade gliomas WHO CNS grade 4." Neuro-Oncology 24, Supplement_2 (September 1, 2022): ii35—ii36. http://dx.doi.org/10.1093/neuonc/noac174.119.
Williams, Erik, Priscilla Brastianos, Hiroaki Wakimoto, Sandro Santagata, Daniel Cahill, and Tareq Juratli. "PATH-08. A COMPREHENSIVE GENOMIC STUDY OF 390 H3F3A-MUTANT PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMAS WHO CNS GRADE 4." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii151. http://dx.doi.org/10.1093/neuonc/noac209.581.
Uchida, Eita, Yukitomo Ishi, Jun Watanabe, Hiam Abdala-Valencia, Benjamin Singer, Samantha Gadd, and Rintaro Hashizume. "DIPG-82. RADIOSENSITIZATION WITH RAD52 INHIBITION IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.135.
Liapodimitri, Athanasia, Kayleigh Lunsford, Ashley R. Tetens, Jordyn Craig-Schwartz, Farhad Vesuna, Venu Raman, and Michael A. Koldobskiy. "DIPG-64. UNRAVELING H3K27M INTERACTIONS IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.117.
Balakrishnan, Illango, Krishna Madhavan, Angela Pierce, Sujatha Venkataraman, and Rajeev Vibhakar. "EXTH-49. A NOVEL THERAPEUTIC ANTIBODY TARGETING DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii220. http://dx.doi.org/10.1093/neuonc/noac209.847.
Boult, Jessica, Diana Carvalho, Ketty Kessler, Maria Vinci, Elisabet Fernandez, Lynn Bjerke, Mariama Fofana, et al. "IMG-09. Characterisation of a panel ofin vivo models of paediatric-type diffuse high-grade glioma (PDHGG) using magnetic resonance imaging." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i78. http://dx.doi.org/10.1093/neuonc/noac079.285.
Gallitto, Matthew, Genesis Los De Santos, Hong-Jian Wei, Xu Zhang, Zhiguo Zhang, and Cheng-Chia Wu. "DIPG-41. CONVECTION ENHANCED DELIVERY-MEDIATED RADIOSENSITIZATION FOR DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.094.
Cartaxo, Rodrigo, Edwin Nieblas-Bedolla, Michael Niculcea, Madeline Miclea, Ruby `. Siada, Kallen Schwark, Sunjong Ji, et al. "HGG-52. MULTI-INTEGRIN TARGETING EFFECTIVELY SUPPRESSES DIFFUSE MIDLINE GLIOMA MIGRATION." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.336.
Damodharan, Sudarshawn, Jeffrey Helgager, and Diane Puccetti. "INNV-13. INDOLENT H3 K27-ALTERED DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii143. http://dx.doi.org/10.1093/neuonc/noac209.553.
Paul, Sonal, Nitin M. Gadgil, and Chetan Chaudhari. "Diffuse Midline Glioma (H3K27M mutant) in Adult: A Diagnostic Challenge." Annals of Pathology and Laboratory Medicine 7, no. 10 (October 29, 2020): C123–127. http://dx.doi.org/10.21276/apalm.2851.
Tsoli, Maria, Caitlin Ung, Dannielle H. Upton, Pooja Venkat, Antonietta Salerno, Ruby Pandher, Chelsea Mayoh, Orazio Vittorio, and David S. Ziegler. "DIPG-35. OVERCOMING THE BLOOD-BRAIN BARRIER CHALLENGE IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.088.
Nduom, Edjah K., John Glod, Desmond A. Brown, Margaret Fagan, Mahalia Dalmage, John Heiss, Seth M. Steinberg, Cody Peer, William D. Figg, and Sadhana Jackson. "Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis." PLOS ONE 18, no. 9 (September 8, 2023): e0291068. http://dx.doi.org/10.1371/journal.pone.0291068.
Ciani, Ludovica, Sandra Laternser, Bettina Kritzer, Kerstin Hasler, Justyna M. Przystal, Mohana R. Velagapudi, Marta M. Alonso, Marta Zalacain, Sabine Müller, and Javad Nazarian. "DIPG-22. TRIPTOLIDE AS A POTENTIALLY PROMISING THERAPY FOR DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i17. http://dx.doi.org/10.1093/neuonc/noad073.069.
Neyazi, Sina, Pruthvi Gowda, Stephen C. Frederico, Cuong M. Nguyen, Maria C. Trissal, Erika P. Portero, John-Paul Haley-Read, et al. "DIPG-14. METABOLIC REPROGRAMMING AS A RESISTANCE MECHANISM IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.067.
Damodharan, Sudarshawn, Peter Favreau, Connie Lebakken, and Mahua Dey. "BIOL-19. DIFFUSE MIDLINE GLIOMA CEREBRAL ORGANOID MODEL AND MULTIOMICS CHARACTERIZATION." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i10. http://dx.doi.org/10.1093/neuonc/noad073.038.
Knowles, Truman, Tina Huang, Shejuan An, Jin Qi, and Amanda Muhs Saratsis. "134 LIN28B as a Novel Therapeutic Target in Diffuse Midline Glioma." Neurosurgery 70, Supplement_1 (April 2024): 28–29. http://dx.doi.org/10.1227/neu.0000000000002809_134.
Mobark, Nahla Ali, Musa Alharbi, Yasser S. Bayoumi, Aymn Albanyan, Ali Abdullah O. Balbaid, Wael abdel Rahman Aljabarat, and Malak Abedalthagafi. "DIPG-35. Personalized treatment for molecularly heterogeneous Diffuse midline glioma, H3 k27-altered Paediatric case." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i26. http://dx.doi.org/10.1093/neuonc/noac079.092.
Tzaridis, Theophilos, Tanja Eisemann, Augusto Faria Andrade, Jennifer L. Hope, Oren Becher, Nada Jabado, Linda M. Bradley, Peter Adams, and Robert Wechsler-Reya. "Abstract 2648: CD155 regulates cell growth and immune evasion in diffuse midline glioma." Cancer Research 84, no. 6_Supplement (March 22, 2024): 2648. http://dx.doi.org/10.1158/1538-7445.am2024-2648.
Jackson, Sadhana, John Glod, Cody Peer, William Figg, Mahalia Dalmage, and Desmond Brown. "TRLS-02. FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i79. http://dx.doi.org/10.1093/neuonc/noad073.305.
Messinger, Dana, Micah Harris, Jessica Cummings, Chase Thomas, Tao Yang, Stefan Sweha, Rinette Woo, et al. "CSIG-09. THERAPEUTIC TARGETING OF PRENATAL PONTINE ID1 SIGNALING IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii40. http://dx.doi.org/10.1093/neuonc/noac209.158.
Tanaka, Shota, Shunsaku Takayanagi, Yuki Shinya, Mariko Kawashima, Masahiro Shin, Hirofumi Nakatomi, and Nobuhito Saito. "DIPG-17. BIOPSY-PROVEN DIFFUSE MIDLINE GLIOMA IN ADOLESCENTS AND YOUNG ADULTS." Neuro-Oncology 22, Supplement_3 (December 1, 2020): iii290. http://dx.doi.org/10.1093/neuonc/noaa222.067.
Tomita, Yusuke, Nozomu Takata, and Oren Becher. "10084-TB-2 IN VITRO CHARACTERIZATION OF COMBINATION THERAPY IN GENETICALLY-ENGINEERED MURINE DIFFUSE MIDLINE GLIOMA MODELS." Neuro-Oncology Advances 5, Supplement_5 (December 1, 2023): v10. http://dx.doi.org/10.1093/noajnl/vdad141.038.
Knowles, Truman, Tina Huang, Jin Qi, Shejuan An, Noah Burket, Scott Cooper, Javad Nazarian, and Amanda M. Saratsis. "LIN28B and Let-7 in Diffuse Midline Glioma: A Review." Cancers 15, no. 12 (June 19, 2023): 3241. http://dx.doi.org/10.3390/cancers15123241.
Pal, Sharmistha, Jakub P. Kaplan, Sylwia A. Stopka, Michael S. Regan, Bradley R. Hunsel, Benjamin H. Kann, Nathalie Y. R. Agar, et al. "DDRE-32. THERAPEUTIC TARGETING OF A NOVEL METABOLIC ADDICTION IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology Advances 3, Supplement_1 (March 1, 2021): i13. http://dx.doi.org/10.1093/noajnl/vdab024.054.
Findlay, Izac J., Geoffry N. De Iuliis, Ryan J. Duchatel, Evangeline R. Jackson, Nicholas A. Vitanza, Jason E. Cain, Sebastian M. Waszak, and Matthew D. Dun. "Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies." Oncogene 41, no. 4 (November 10, 2021): 461–75. http://dx.doi.org/10.1038/s41388-021-02102-y.
Oza, Viral, Shilpa Sampathi, Yelena Chernyavskava, Kenan Flores, and Jessica Blackburn. "Abstract 1126: Extracellular vesicle mediated radioresistance in H3K27M-diffuse midline glioma." Cancer Research 84, no. 6_Supplement (March 22, 2024): 1126. http://dx.doi.org/10.1158/1538-7445.am2024-1126.
Patel, Palak, Bharti Kukreja, Brian Kalish, Sanja Pajovic, and Cynthia Hawkins. "TMIC-77. UNVEILING THE DEPTHS: EXPLORING DIFFUSE MIDLINE GLIOMA, TUMORIGENESIS, AND RADIATION RESISTANCE." Neuro-Oncology 25, Supplement_5 (November 1, 2023): v295—v296. http://dx.doi.org/10.1093/neuonc/noad179.1142.
du Chatinier, Aimée, Michaël H. Meel, Arvid I. Das, Dennis S. Metselaar, Piotr Waranecki, Marianna Bugiani, Marjolein Breur, et al. "MODL-16. Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i172. http://dx.doi.org/10.1093/neuonc/noac079.639.
Moloney, Sam, Vickyanne Carruthers, Melissa J. Davis, Dharmesh D. Bhuva, Cristina Mignone, Susan Singh, Rebecca E. Gardiner, Santosh Valvi, David D. Eisenstat, and Jordan R. Hansford. "DIPG-54. PREDICTING EARLY DEATH IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.107.
Frederico, Stephen C., Sina Neyazi, Pruthvi Gowda, Cuong Nguyen, Maria Trissal, Erika P. Portero, John-Paul Haley-Read, et al. "Revealing and targeting metabolic drivers contributing to treatment escape in diffuse midline glioma." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): 10038. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.10038.
Di Ruscio, Valentina, Giada Del Baldo, Francesco Fabozzi, Maria Vinci, Antonella Cacchione, Emmanuel de Billy, Giacomina Megaro, Andrea Carai, and Angela Mastronuzzi. "Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle." Diagnostics 12, no. 9 (August 25, 2022): 2064. http://dx.doi.org/10.3390/diagnostics12092064.
Parthasarathy, Akhila, Marc Garcia-Moure, Jiasen He, Dong Ho Shin, Andrew G. Gillard, Andres Lopez-Rivas, Lethan A. Hampton, et al. "DIPG-45. TARGETING HYPERACETYLATION IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS USING ONCOLYTIC ADENOVIRUSES." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.098.
Gestrich, Catherine, Kristina Grieco, Hart Lidov, Keith Ligon, Sandro Santagata, Kee Kiat Yeo, Sanda Alexandrescu, and David Meredith. "DIPG-44. H3K27-altered diffuse midline gliomas with secondary driver molecular alterations." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i28. http://dx.doi.org/10.1093/neuonc/noac079.101.